Literature DB >> 26818783

The cast of clasts: catabolism and vascular invasion during bone growth, repair, and disease by osteoclasts, chondroclasts, and septoclasts.

Paul R Odgren1, Hanna Witwicka1, Pablo Reyes-Gutierrez1.   

Abstract

Three named cell types degrade and remove skeletal tissues during growth, repair, or disease: osteoclasts, chondroclasts, and septoclasts. A fourth type, unnamed and less understood, removes nonmineralized cartilage during development of secondary ossification centers. "Osteoclasts," best known and studied, are polykaryons formed by fusion of monocyte precursors under the influence of colony stimulating factor 1 (CSF)-1 (M-CSF) and RANKL. They resorb bone during growth, remodeling, repair, and disease. "Chondroclasts," originally described as highly similar in cytological detail to osteoclasts, reside on and degrade mineralized cartilage. They may be identical to osteoclasts since to date there are no distinguishing markers for them. Because osteoclasts also consume cartilage cores along with bone during growth, the term "chondroclast" might best be reserved for cells attached only to cartilage. "Septoclasts" are less studied and appreciated. They are mononuclear perivascular cells rich in cathepsin B. They extend a cytoplasmic projection with a ruffled membrane and degrade the last transverse septum of hypertrophic cartilage in the growth plate, permitting capillaries to bud into it. To do this, antiangiogenic signals in cartilage must give way to vascular trophic factors, mainly vascular endothelial growth factor (VEGF). The final cell type excavates cartilage canals for vascular invasion of articular cartilage during development of secondary ossification centers. The "clasts" are considered in the context of fracture repair and diseases such as arthritis and tumor metastasis. Many observations support an essential role for hypertrophic chondrocytes in recruiting septoclasts and osteoclasts/chondroclasts by supplying VEGF and RANKL. The intimate relationship between blood vessels and skeletal turnover and repair is also examined.

Entities:  

Keywords:  Angiogenesis; arthritis; bone repair; endochondral ossification; growth plate; pericyte

Mesh:

Year:  2016        PMID: 26818783      PMCID: PMC4912663          DOI: 10.3109/03008207.2016.1140752

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  99 in total

Review 1.  The bromodomain interaction module.

Authors:  Panagis Filippakopoulos; Stefan Knapp
Journal:  FEBS Lett       Date:  2012-05-03       Impact factor: 4.124

2.  TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.

Authors:  B R Wong; D Besser; N Kim; J R Arron; M Vologodskaia; H Hanafusa; Y Choi
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

3.  Unerupted dentition secondary to congenital osteopetrosis in the Osborne-Mendel rat.

Authors:  W R Cotton; J F Gaines
Journal:  Proc Soc Exp Biol Med       Date:  1974-06

Review 4.  Chondrocyte proliferation and differentiation.

Authors:  Manuela Wuelling; Andrea Vortkamp
Journal:  Endocr Dev       Date:  2011-08-22

5.  Immunolocalization of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice.

Authors:  Yasunori Sakakura; Eichi Tsuruga; Kazuharu Irie; Yoichiro Hosokawa; Hiroaki Nakamura; Toshihiko Yajima
Journal:  J Anat       Date:  2005-10       Impact factor: 2.610

6.  Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene.

Authors:  N Kim; P R Odgren; D K Kim; S C Marks; Y Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

7.  An SNX10 mutation causes malignant osteopetrosis of infancy.

Authors:  Memet Aker; Alex Rouvinski; Saar Hashavia; Asaf Ta-Shma; Avraham Shaag; Shamir Zenvirt; Shoshana Israel; Michael Weintraub; Albert Taraboulos; Zvi Bar-Shavit; Orly Elpeleg
Journal:  J Med Genet       Date:  2012-04       Impact factor: 6.318

Review 8.  The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?

Authors:  M A Karsdal; A C Bay-Jensen; R J Lories; S Abramson; T Spector; P Pastoureau; C Christiansen; M Attur; K Henriksen; S R Goldring; V Kraus
Journal:  Ann Rheum Dis       Date:  2013-11-27       Impact factor: 19.103

Review 9.  Denosumab--a powerful RANKL inhibitor to stop lytic metastases and other bone loss actions by osteoclasts.

Authors:  László Kopper
Journal:  Pathol Oncol Res       Date:  2012-05-16       Impact factor: 3.201

10.  Cellular and molecular bases of skeletal regeneration: what can we learn from genetic mouse models?

Authors:  Rana Abou-Khalil; Céline Colnot
Journal:  Bone       Date:  2014-04-04       Impact factor: 4.398

View more
  20 in total

1.  Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII.

Authors:  Sun H Peck; John W Tobias; Eileen M Shore; Neil R Malhotra; Mark E Haskins; Margret L Casal; Lachlan J Smith
Journal:  Bone       Date:  2019-08-20       Impact factor: 4.398

2.  Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells.

Authors:  Filipa Lopes-Coelho; Carolina Nunes; Sofia Gouveia-Fernandes; Rita Rosas; Fernanda Silva; Paula Gameiro; Tânia Carvalho; Maria Gomes da Silva; José Cabeçadas; Sérgio Dias; Luís G Gonçalves; Jacinta Serpa
Journal:  Oncotarget       Date:  2017-08-16

3.  Origin and development of septoclasts in endochondral ossification of mice.

Authors:  Yasuhiko Bando; Hide Sakashita; Fuyoko Taira; Genki Miyake; Yudai Ogasawara; Koji Sakiyama; Yuji Owada; Osamu Amano
Journal:  Histochem Cell Biol       Date:  2018-02-20       Impact factor: 4.304

Review 4.  Mesenchymal stem cell-macrophage crosstalk and bone healing.

Authors:  Jukka Pajarinen; Tzuhua Lin; Emmanuel Gibon; Yusuke Kohno; Masahiro Maruyama; Karthik Nathan; Laura Lu; Zhenyu Yao; Stuart B Goodman
Journal:  Biomaterials       Date:  2018-01-02       Impact factor: 12.479

5.  Spatial and chronological localization of septoclasts in the mouse Meckel's cartilage.

Authors:  Hide Sakashita; Yasuhiko Bando; Arata Nagasaka; Koji Sakiyama; Go Onozawa; Fuyoko Taira; Yudai Ogasawara; Yuji Owada; Hideaki Sakashita; Osamu Amano
Journal:  Histochem Cell Biol       Date:  2022-02-23       Impact factor: 4.304

6.  Osteoclast depletion with clodronate liposomes delays fracture healing in mice.

Authors:  Hsuan-Ni Lin; J Patrick O'Connor
Journal:  J Orthop Res       Date:  2016-10-06       Impact factor: 3.494

7.  Osteoprotegerin deficiency leads to deformation of the articular cartilage in femoral head.

Authors:  Yi Liu; Jianping Ge; Danying Chen; Yuteng Weng; Haiming Du; Yao Sun; Qi Zhang
Journal:  J Mol Histol       Date:  2016-08-19       Impact factor: 2.611

8.  Effects of hypothalamic leptin gene therapy on osteopetrosis in leptin-deficient mice.

Authors:  Kenneth A Philbrick; Stephen A Martin; Amy R Colagiovanni; Adam J Branscum; Russell T Turner; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2017-11-30       Impact factor: 4.286

9.  Epiphyseal cartilage canal architecture and extracellular matrix remodeling in mucopolysaccharidosis VII dogs at the onset of postnatal growth.

Authors:  Zhirui Jiang; Casey P Johnson; Olli Nykänen; Mikko Nissi; Yian Khai Lau; Meilun Wu; Margret L Casal; Lachlan J Smith
Journal:  Connect Tissue Res       Date:  2021-01-11       Impact factor: 3.417

Review 10.  The hypertrophic chondrocyte: To be or not to be.

Authors:  Shawn A Hallett; Wanida Ono; Noriaki Ono
Journal:  Histol Histopathol       Date:  2021-06-17       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.